Lisata TherapeuticsLSTA
13F holders, Q3 2025 (September 30)21holders +1
3new positions
2sold out
1famous investor
$2.62avg. 13F price*
At the end of Q3 2025, 21 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($709K), Renaissance Technologies ($306K) and BML Capital Management, LLC ($288K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lisata Therapeutics Inc.
- CUSIP
- 128058302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $94K |
| Exits | 2 | $21K |
All 13F filers, Q2 2025 → Q3 2025: 68,592 shares bought and 111,914 shares sold, net −43,322 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Vanguard Group Inc. | 0.00% | Add +6.4% | 270,514 | $709K |
| Renaissance Technologies | 0.00% | Add +13.4% | 116,622 | $306K |
| BML Capital Management, LLC | 0.26% | Reduce -47.6% | 109,841 | $288K |
| Geode Capital Management, LLC | 0.00% | Add +3.6% | 63,260 | $166K |
| BlackRock, Inc. | 0.00% | Add +0.1% | 54,890 | $144K |
| Ground Swell Capital, LLC | 0.14% | New | 23,774 | $62K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -18.8% | 20,947 | $55K |
| State Street Corp. | 0.00% | No change | 14,348 | $38K |
| Cerity Partners LLC | 0.00% | No change | 12,183 | $31K |
| XTX Topco Ltd | 0.00% | New | 11,111 | $29K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 10,417 | $27K |
| Northern Trust Corp. | 0.00% | No change | 10,268 | $27K |
| HighTower Advisors, LLC | 0.00% | No change | 10,042 | $26K |
| Royal Bank of Canada | 0.00% | No change | 5,912 | $15K |
| Founders Capital Management | 0.00% | No change | 2,000 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +26.3% | 1,671 | $4K |
| Connective Capital Management, LLC | 0.00% | New | 1,016 | $3K |
| Morgan Stanley | 0.00% | Reduce -7.1% | 208 | $545 |
| SBI Securities Co., Ltd. | 0.00% | No change | 140 | $367 |
| Barclays PLC | 0.00% | No change | 4 | $10 |
| Cheviot Value Management, LLC | 0.00% | No change | 3 | $8 |
"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.